Format

Send to

Choose Destination
Clin Rheumatol. 2008 Apr;27(4):529-32. Epub 2007 Oct 16.

Oral bisphosphonates in treatment of transient osteoporosis.

Author information

1
Department of Internal Medicine, Division of Rheumatology, American University of Beirut Medical Center, New York, NY, USA.

Abstract

Transient osteoporosis is a rare clinical syndrome of unknown etiology. It is believed that this syndrome is self-limiting; however, the data in the literature support the use of anti-resorptive agents that may reduce pain and decrease the duration of the illness. Herein, we describe two cases of transient osteoporosis of the hip and one case of transient osteoporosis of the knee where the use of oral bisphosphonates provided successful objective and subjective outcome.

PMID:
17938988
DOI:
10.1007/s10067-007-0766-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center